Evidence map›Paper›PMID 41890078›Full record

ArticlebioRxiv : the preprint server for biology2026

PalmaClust: A graph-fusion framework leveraging the Palma ratio for robust ultra-rare cell type detection in scRNA-seq data.

Xingzhi Niu, Jieqiong Wang, Shibiao Wan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xingzhi NiuDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, 68198, NE, USA.ORCID 0009-0008-6898-8314
Jieqiong WangDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, 68198, NE, USA.
Shibiao WanDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, 68198, NE, USA.ORCID 0000-0003-0661-2684

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
Using Patient-Reported Outcomes, Inflammatory Profiles, and Cardiovascular Phenogroups to Expand the Definition of Heart Failure with Preserved Ejection FractionP20GM152326 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Rebekah L. Gundry · 2024 to 2026
$10.3M
Leveraging Heterogenous Common Fund Data Sets and Beyond for Identifying Lung Cancer SubtypesR03OD038391 · OD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WAN, SHIBIAO, WANG, JIEQIONG · 2024 to 2024
$307k
NIGMS NIH HHS P20 GM103427NIGMS NIH HHS P20 GM152326NIH HHS R03 OD038391
6 · The paper itself

Abstract

Motivation: Single-cell RNA sequencing (scRNA-seq) is routinely used to build atlases of tissues, resolve developmental trajectories, and characterize disease microenvironments. Yet many biologically and clinically meaningful populations-including transient progenitors, therapy-resistant tumor subclones, and antigen-specific lymphocytes-occur at very low frequencies (<1%) and are easily missed by standard clustering pipelines. Existing approaches often require extensive manual curation, rely on known marker genes, or trade sensitivity for unacceptable false positive rates due to the insensitivity of metrics like the Gini index to heavy-tailed distributions. A scalable, statistically grounded method is needed to sensitively detect rare populations while providing calibrated confidence and interpretable molecular signatures. Results: We present PalmaClust, a graph-fusion clustering framework that repurposes Palma ratio-a tail-sensitive inequality metric in sociology-to identify marker genes driven by extreme sparsity. PalmaClust constructs and fuses multiple K-Nearest Neighbor (KNN) graphs derived from complementary gene-selection statistics including the Palma ratio, Gini index, and Fano factor. It employs a local refinement strategy that re-prioritizes Palma-ranked genes within parent clusters. Benchmarking across diverse public scRNA-seq datasets confirms that PalmaClust consistently outperforms state-of-the-art baselines, improving rare-class F1 scores by at least 20% (absolute) while maintaining high global clustering stability. Further studies demonstrate that the Palma ratio-derived graph layer is essential for capturing ultra-rare signatures that other views miss. Availability: https://github.com/wan-mlab/PalmaClust.

Identifiers

PMID41890078
PMCPMC13015274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.